Literature DB >> 27651575

Obstetric Outcome During an Era of Active Management for Obstetrics Cholestasis.

Nalini Sharma1, S Panda1, Ahanthem Santa Singh1.   

Abstract

OBJECTIVE: To study the incidence, maternal, and perinatal outcomes in intrahepatic cholestasis of pregnancy with active management.
MATERIALS AND METHODS: This observational study included 48 cases diagnosed as intrahepatic cholestasis of pregnancy. Medical treatment and active management (fetal surveillance and termination of pregnancy at 37-38 weeks) were offered to all. Maternal and perinatal outcomes are studied.
RESULTS: Incidence of ICP was 2.4 %. More than 86 % of patients presented with generalized pruritus mostly after 30 weeks. Incidences of Intrapartum abnormal cardiotocography (12.5 %) and thick meconium (8.33 %) were high. Cesarean section rate was high (41.66 %). Most common indications were CDMR, fetal distress, and non-progress of labor. Incidence of preterm labor, IUGR, Apgar score (<7), and neonatal admission rate were not high. There was one stillbirth at 36 weeks of gestation. Serum transaminase levels tended to be higher in patients with poor perinatal outcomes, such as stillbirth, fetal distress, and meconium-stained amniotic fluid.
CONCLUSION: Serum transaminase levels tended to be higher in patients with poor perinatal outcome. Perinatal outcome is good with active management, at the cost of higher LSCS rate. Further randomized controlled trial of early versus spontaneous delivery may be justified.

Entities:  

Keywords:  Active management; Intrahepatic cholestasis of pregnancy; Obstetrics cholestasis; Perinatal outcome

Year:  2015        PMID: 27651575      PMCID: PMC5016408          DOI: 10.1007/s13224-015-0768-8

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  9 in total

Review 1.  Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management.

Authors:  F Lammert; H U Marschall; A Glantz; S Matern
Journal:  J Hepatol       Date:  2000-12       Impact factor: 25.083

2.  Intrahepatic cholestasis of pregnancy: correlation of preterm delivery with bile acids.

Authors:  Ozlem Pata; Eser Vardarelı; Alihan Ozcan; Mustafa Serteser; Ibrahim Unsal; Murat Saruç; Cihat Unlü; Nurdan Tözün
Journal:  Turk J Gastroenterol       Date:  2011-12       Impact factor: 1.852

Review 3.  Intrahepatic cholestasis of pregnancy--a heterogeneous group of pregnancy-related disorders?

Authors:  Ulrich Beuers; Thomas Pusl
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

Review 4.  Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems.

Authors:  Jurate Kondrackiene; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

Review 5.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

6.  Pregnancy outcome with intrahepatic cholestasis.

Authors:  S Heinonen; P Kirkinen
Journal:  Obstet Gynecol       Date:  1999-08       Impact factor: 7.661

7.  Obstetric cholestasis, outcome with active management: a series of 70 cases.

Authors:  Anna P Kenyon; C Nelson Piercy; J Girling; C Williamson; R M Tribe; A H Shennan
Journal:  BJOG       Date:  2002-03       Impact factor: 6.531

8.  Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group.

Authors:  Catherine Williamson; Laura M Hems; Dimitrios G Goulis; Ian Walker; Jennifer Chambers; Oscar Donaldson; Michael Swiet; Desmond G Johnston
Journal:  BJOG       Date:  2004-07       Impact factor: 6.531

9.  Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates.

Authors:  Anna Glantz; Hanns-Ulrich Marschall; Lars-Ake Mattsson
Journal:  Hepatology       Date:  2004-08       Impact factor: 17.425

  9 in total
  2 in total

1.  Serum Bile Acids in Intrahepatic Cholestasis of Pregnancy (ICP), Versus Pregnant and Nonpregnant Controls in Asian Indian Women and a Proposed Scoring to Optimize Management in ICP.

Authors:  Nutan Agarwal; Reeta Mahey; Vidushi Kulshrestha; Alka Kriplani; Anoop Saraya; Vikas Sachdev
Journal:  J Obstet Gynaecol India       Date:  2021-06-26

2.  The prevalence and pregnancy outcomes of intrahepatic cholestasis of pregnancy: A retrospective clinical audit review.

Authors:  Fergus W Gardiner; Ruth McCuaig; Chris Arthur; Thomas Carins; Adam Morton; Josephine Laurie; Teresa Neeman; Boon Lim; Michael J Peek
Journal:  Obstet Med       Date:  2018-10-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.